Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (7), 883-894

Breathprinting and Early Diagnosis of Lung Cancer


Breathprinting and Early Diagnosis of Lung Cancer

Gaetano Rocco et al. J Thorac Oncol.


The electronic nose (e-nose) is a promising technology as a useful addition to the currently available modalities to achieve lung cancer diagnosis. The e-nose can assess the volatile organic compounds detected in the breath and derived from the cellular metabolism. Volatile organic compounds can be analyzed to identify the individual chemical elements as well as their pattern of expression to reproduce a sensorial combination similar to a fingerprint (breathprint). The e-nose can be used alone, mimicking the combinatorial selectivity of the human olfactory system, or as part of a multisensorial platform. This review analyzes the progress made by investigators interested in this technology as well as the perspectives for its future utilization.

Keywords: Biomarkers; Breathprint; Electronic nose; Lung cancer.

Similar articles

See all similar articles

Cited by 1 article

MeSH terms